Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2023 Dec;82(3):613-621.
doi: 10.1007/s12020-023-03455-y. Epub 2023 Jul 25.

Is unicentric familial papillary thyroid microcarcinoma different from multicentric?

A Ríos  1   2 , J Ruiz-Pardo  3 , A Balaguer-Román  4   5 , J A Puñal  6 , P Moreno  7 , E Mercader  8 , E Ferrero  9 , M A Morlán  10 , J Martín  11 , M Durán  12   13 , J M Bravo  14 , D Casanova  15 , M P Salvador-Egea  16 , N M Torregrosa  17 , A Exposito-Rodríguez  18 , G Martínez-Fernández  19 , A M Carrión  20 , O Vidal  21 , F Herrera  22 , G Ruiz-Merino  23 , J M Rodríguez  4   5
Affiliations
Observational Study

Is unicentric familial papillary thyroid microcarcinoma different from multicentric?

A Ríos et al. Endocrine. 2023 Dec.

Abstract

Background: Familial papillary thyroid microcarcinoma (FPTMC) appears to be more aggressive than sporadic papillary thyroid microcarcinoma (SPTMC). However, there are authors who indicate that unicentric FPTMC has a similar prognosis to SPTMC. The objective is to analyze whether unicentric FPTMC has a better prognosis than multicentric FPTMC.

Design and methods: Type of study: National multicenter longitudinal analytical observational study.

Study population: Patients with FPTMC.

Study groups: Two groups were compared: Group A (unicentric FPTMC) vs. Group B (multicentric FPTMC).

Study variables: It is analyzed whether between the groups there are: a) differentiating characteristics; and b) prognostic differences.

Statistical analysis: Cox regression analysis and survival analysis.

Results: Ninety-four patients were included, 44% (n = 41) with unicentric FPTMC and 56% (n = 53) with multicentric FPTMC. No differences were observed between the groups according to socio-familial, clinical or histological variables. In the group B a more aggressive treatment was performed, with higher frequency of total thyroidectomy (99 vs. 78%; p = 0.003), lymph node dissection (41 vs. 15%; p = 0.005) and therapy with radioactive iodine (96 vs. 73%; p = 0.002). Tumor stage was similar in both groups (p = 0.237), with a higher number of T3 cases in the group B (24 vs. 5%; p = 0.009). After a mean follow-up of 90 ± 68.95 months, the oncological results were similar, with a similar disease persistence rate (9 vs. 5%; p = 0.337), disease recurrence rate (21 vs. 8%; p = 0.159) and disease-free survival (p = 0.075).

Conclusions: Unicentric FPTMC should not be considered as a SPTMC due to its prognosis is similar to multicentric FPTMC.

Keywords: Familial papillary thyroid microcarcinoma; Multicentric; Unicentric.

PubMed Disclaimer

References

    1. A. Miyauchi, Clinical trials of active surveillance of papillary microcarcinoma of the thyroid. World J. Surg. 40, 516–22 (2016). https://doi.org/10.1007/s00268-015-3392-y - DOI - PubMed - PMC
    1. A. Ríos, J.M. Rodríguez, D. Navas, A. Cepero, N.M. Torregrosa, M.D. Balsalobre et al. Family screening in familial papillary carcinoma: the early detection of thyroid disease. Ann. Surg. Oncol. 23, 2564–70 (2016). https://doi.org/10.1245/s10434-016-5149-8 - DOI - PubMed
    1. M. Capezzone, C. Secchi, N. Fralassi, S. Cantara, L. Brilli, C. Ciuoli et al. Should familial disease be considered as a negative prognostic factor in micropapillary thyroid carcinoma? J. Endocrinol. Invest 42, 1205–13 (2019). https://doi.org/10.1007/s40618-019-01039-0 - DOI - PubMed
    1. E.L. Maxwell, F.T. Hall, J.L. Freeman, Familial non‐medullary thyroid cancer: a matched‐case control study. Laryngoscope 114, 2182–6 (2004). https://doi.org/10.1097/01.mlg.0000149454.91005.65 - DOI - PubMed
    1. V. Nosé, Familial thyroid cancer: a review. Mod. Pathol. 24, S19–33 (2011). https://doi.org/10.1038/modpathol.2010.147 - DOI - PubMed

Publication types

MeSH terms

Substances

Supplementary concepts

LinkOut - more resources